OBESITY AND MS
January 22, 2021
Obesity increases risk of developing MS especially in adolescent women. Later obesity increases risk of MRI progression and disability progression.During the current Covid restrictions there has been increased stresses for everyone. Working virtually, cooking at home but also snacking have changed eating habits. Having family at home has been rewarding but hard. Being alone and socially isolated and not being able to meet friends in restaurants has increased stress and depression. People have...
COVID-19 Vaccine Recommendation for MS Patients
January 8, 2021
These are our recommendations regarding COVID-19 vaccination for our MS patients as of Jan 8, 2021. As more information becomes available, we will update it. The two vaccines that are currently approved, ( pfizer and moderna) have no specific contra-indication for patients with MS or on immunesuppressive treatmentWith regard to the impact of disease modifying therapies patients may be taking, it is advised that they continue their injectable or oral medications without interruption.With regard...
Severity of COVID-19 Infection in MS patients
December 31, 2020
In a large study of 347 patients in a French MS registry in France, the risks associated with more severe COVID-19 disease were similar to that in the general population -age and obesity, progressive disease and more severe baseline disability. Among the DMTs, the more immunosuppressive treatments were associated with more severe COVID-19 disease. Even though the numbers were small, among 4 patients in this analysis who required mechanical ventilation, three were on anti-CD20 targeted therapy...
